Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection

Abstract Background Chronic-active antibody mediated rejection (c-aABMR) is a major contributor to long-term kidney allograft loss. We conducted a retrospective analysis to establish the efficacy of treatment with intravenous immunoglobulins (IVIG) and pulse methylprednisolone (MP) of patients with...

Full description

Bibliographic Details
Main Authors: Kasia A. Sablik, Marian C. Clahsen-van Groningen, Caspar W. N. Looman, Jeffrey Damman, Madelon van Agteren, Michiel G. H. Betjes
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Nephrology
Subjects:
Transplantation
Renal allograft rejection
C-aABMR
IVIG
MP
Treatment
Online Access:http://link.springer.com/article/10.1186/s12882-019-1385-z

Internet

http://link.springer.com/article/10.1186/s12882-019-1385-z

Similar Items